Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: a randomized, double-blinded, placebo-controlled phase 3 trial

Name: Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: a randomized, double-blinded, placebo-controlled phase 3 trial
Creator: Amy S. Paller
Published: 2020-09-25T07:50:57.661Z
Keywords: Atopic Dermatitis

Paller, Amy S.; Shumel, Brad

doi:10.17632/6k45whwfcp.1

Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: a randomized, double-blinded, placebo-controlled phase 3 trial

Published: 25 September 2020| Version 1 | DOI: 10.17632/6k45whwfcp.1

Contributors:

Amy S. Paller, Brad Shumel

Description

Author video for the article: Paller AS, et al. Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: a randomized, double-blinded, placebo-controlled phase 3 trial. J Am Acad Dermatol. 2020 Jun 20;S0190-9622(20)31152-X. doi: 10.1016/j.jaad.2020.06.054

Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: a randomized, double-blinded, placebo-controlled phase 3 trial

Description

Files

Categories

Related Links

Licence